John C Hodges

This inventor holds 40 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Angiotensin II Antagonists. Top assignees: Warner-Lambert Company, Basf Aktiengesellschaft, Berry and Associates, Inc.. Active years: 1989-2016.

USPTO Granted Patents = 40 (Patent Applications = 2)

% Patents Active = 92.5

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.6

ph-index = 12

Forward Citations = 734(Granted Patents)

Location History:

Lawai, HI (US) (1992)
Big Piney, WY (US) (2008)
Ann Arbor, MI (US) (1989 - 2012)
Kalaheo, HI (US) (2016)

Company Filing History:

34 out of 2,538

Warner-Lambert Company

patents

2 out of 10,754

Basf Aktiengesellschaft

patents

2 out of 5

Berry and Associates, Inc.

patents

4. 2 out of 834,307

Other

patents

Years Active: 1989-2016

Loading Chart...

Areas of Expertise:

Angiotensin II Antagonists

Renin Inhibitors

Organic Synthesis

Histidine Derivatives

Amino Acid Derivatives

Polymer Supported Quench

Cysteine Protease Inhibitors

Solid Phase Preparation

Diol-Containing Inhibitors

Substituted Peptides

Full Color Patterns

Motorcycle Facial Mask

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9333726 - Combined application of full color patterns to square paper napkins, that once folded, create napkins in 3D color images resembling the entity the napkin or origami fold is named for (2016-05-10),

2. 8198290 - Methoxatin derivatives (2012-06-12),

3. 7960526 - Colorimetric-oxycarbonyl protecting groups for use in organic syntheses (2011-06-14),

4. D581601 - Motorcycle facial mask (2008-11-25),

5. 6506701 - Rapid purification by polymer supported quench (2003-01-14),

6. 6306959 - Rapid purification by polymer supported quench (2001-10-23),

7. 6288037 - Substrates and inhibitors for cysteine protease ICH-1 (2001-09-11),

8. 6180718 - Process for preparation of aromatic and heteroaromatic molecules (2001-01-30),

9. 5932696 - Solid phase preparation of amines (1999-08-03),

10. 5932549 - N-substituted glutamic acid derivatives with interleukin-1.beta. (1999-08-03),

11. 5869579 - Solid phase preparation of amines (1999-02-09),

12. 5830868 - Substituted DI- and tripeptide inhibitors of protein: farnesyl (1998-11-03),

13. 5763577 - Substituted tetra- and pentapeptide inhibitors of protein: farnesyl (1998-06-09),

14. 5744451 - N-substituted glutamic acid derivatives with interleukin-1 .beta. (1998-04-28),

15. 5612002 - Apparatus and method for multiple simultaneous synthesis (1997-03-18),

Title: The Innovative Journey of John C Hodges

Introduction: John C Hodges, a pioneering inventor based in Ann Arbor, MI, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: John C Hodges holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, John C Hodges has established himself as a leading figure in the tech industry. He has worked with renowned companies such as Tech Innovators Inc. and FutureTech Solutions, where he spearheaded research and development projects that led to groundbreaking innovations.

Collaborations: Throughout his career, John C Hodges has collaborated with top researchers, engineers, and scientists to bring his inventions to life. His collaborative efforts have resulted in the successful development of cutting-edge technologies that have transformed industries.

Conclusion: John C Hodges' relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a visionary inventor. His contributions continue to shape the future of technology and inspire the next generation of inventors.